Ahuman ceIIIine derived from acute myeIoid Ieu kemia (AML) . Secondary AML. AbIe to differentiate to megakaryocyte-Iike ce II5 .

Ahuman ceIIIine derived from acute
myeIoid Ieu kemia (AML) . Secondary AML.
AbIe to differentiate to megakaryocyte-Iike
ce II5 . Struktur
CAS-Nr.
Englisch Name:
Ahuman ceIIIine derived from acute myeIoid Ieu kemia (AML) . Secondary AML. AbIe to differentiate to megakaryocyte-Iike ce II5 .
Synonyma:
HYT-1;Ahuman ceIIIine derived from acute myeIoid Ieu kemia (AML) . Secondary AML. AbIe to differentiate to megakaryocyte-Iike ce II5 .
CBNumber:
CB821463068
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

Ahuman ceIIIine derived from acute myeIoid Ieu kemia (AML) . Secondary AML. AbIe to differentiate to megakaryocyte-Iike ce II5 . Eigenschaften

Sicherheit

Ahuman ceIIIine derived from acute myeIoid Ieu kemia (AML) . Secondary AML. AbIe to differentiate to megakaryocyte-Iike ce II5 . Chemische Eigenschaften,Einsatz,Produktion Methoden

Ahuman ceIIIine derived from acute myeIoid Ieu kemia (AML) . Secondary AML. AbIe to differentiate to megakaryocyte-Iike ce II5 . Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Ahuman ceIIIine derived from acute myeIoid Ieu kemia (AML) . Secondary AML. AbIe to differentiate to megakaryocyte-Iike ce II5 . Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Guangdong Fanpu Biotechnology Co., Ltd. 19513720913
2708713838@qq.com China 4720 58

  • Ahuman ceIIIine derived from acute myeIoid Ieu kemia (AML) . Secondary AML. AbIe to differentiate to megakaryocyte-Iike ce II5 .
  • HYT-1
Copyright 2019 © ChemicalBook. All rights reserved